Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients-Reference-Cited by-同舟云学术

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients

Published:2021-09-25 Issue:2 Volume:36 Page:476-481
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Blixt Lisa,Bogdanovic Gordana,Buggert Marcus,Gao Yu,Hober Sophia,Healy Katie,Johansson Hemming,Kjellander Christian,Mravinacova Sara^ORCID,Muschiol Sandra,Nilsson Peter^ORCID,Palma Marzia^ORCID,Pin Elisa,Smith C. I. Edvard^ORCID,Stromberg Olga,Sällberg Chen Margaret^ORCID,Zain Rula^ORCID,Hansson Lotta^ORCID,Österborg Anders^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01424-w.pdf

Reference22 articles.

1. Langerbeins P, Eichhorst B. Immune dysfunction in patients with chronic lymphocytic leukemia and challenges during COVID-19 pandemic. Acta Haematol. 2021;144:508–18.

2. Palma M, Gentilcore G, Heimersson K, Mozaffari F, Nasman-Glaser B, Young E, et al. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers. Haematologica. 2017;102:562–72.

3. Mulder TA, Pena-Perez L, Berglof A, Meinke S, Estupinan HY, Heimersson K, et al. Ibrutinib has time-dependent on- and off-target effects on plasma biomarkers and immune cells in chronic lymphocytic leukemia. Hemasphere. 2021;5:e564.

4. Rogers KA, Mousa L, Zhao Q, Bhat SA, Byrd JC, El Boghdadly Z, et al. Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies. Leukemia. 2019;0:2527–30.

5. Mato AR, Roeker LE, Lamanna N, Allan JN, Leslie L, Pagel JM, et al. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020;136:1134–43.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

2. Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review;Iranian Journal of Allergy, Asthma and Immunology;2024-08-10

3. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

4. Long-Lasting SARS-CoV-2 Infection With Post-COVID-19 Chronic Interstitial Pneumonia in a Patient With Chronic Lymphocytic Leukemia Treated Successfully With Intravenous Immunoglobulin;Cureus;2024-01-08

5. Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis;Revista da Associação Médica Brasileira;2024